drug

JZP3507

1 story · latest Nov 9, 2026

Follow JZP3507. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Code: ONC206
Trials: 1 registered trial in coverage

Relationships

Developed by Jazz Pharmaceuticals

Timeline

Jazz Pharmaceuticals' Phase I ONC206 trial in CNS neoplasms updated, remains active not recruiting

Nov 9Trial updateJazz Pharmaceuticals JZP3507

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.